other · Zenodo (CERN European Organization for Nuclear Research)
Abstract: The human gut microbiome, comprising trillions of microorganisms, functions as an"essential organ" with metabolic, immunological, and protective roles critical to host health.This review synthesizes current evidence on the relationship between gut microbiota andchronic disease pathogenesis, drawing from 50 high-impact studies identified through acomprehensive literature search. Dysbiosis microbial imbalance is strongly associated withmetabolic disorders (obesity, type 2 diabetes, NAFLD), cardiovascular disease, inflammatorybowel disease, autoimmune conditions, neurodegenerative diseases, and certain cancers. Keymechanisms include immune modulation, regulation of intestinal barrier integrity, andproduction of bioactive metabolites (short-chain fatty acids, trimethylamine N-oxide) thatinfluence host physiology. Environmental factors, particularly diet and lifestyle, shapemicrobial composition, while therapeutic interventions including dietary modification,probiotics, and faecal microbiota transplantation show promise but variable efficacy. Despitesignificant advances in understanding microbiome-disease associations through highthroughput sequencing, challenges remain in establishing causality due to confoundingvariables and inter-individual variability. This review highlights the gut microbiome's pivotalrole in chronic disease pathogenesis while identifying critical research gaps requiringlongitudinal studies, standardised dysbiosis definitions, and rigorous validation of personalisedtherapeutic approaches.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.19508539
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.